Catalyst Pharmaceuticals Inc (FRA:CN2)
€ 27.3 (0%) Market Cap: 3.39 Bil Enterprise Value: 2.72 Bil PE Ratio: 18.10 PB Ratio: 3.80 GF Score: 93/100

Catalyst Pharmaceuticals Inc (FRA:CN2) Transcripts

  • 1